These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23753907)

  • 1. Error in Author's Name in: Intravitreal Bevacizumab for Peripapillary Choroidal Neovascular Membranes.
    Arch Ophthalmol; 2012 Nov; 130(11):1473. PubMed ID: 23753907
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of peripapillary choroidal neovascular membranes with intravitreal bevacizumab.
    Figueroa MS; Noval S; Contreras I
    Br J Ophthalmol; 2008 Sep; 92(9):1244-7. PubMed ID: 18621798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab for peripapillary subretinal neovascular membrane associated to papilledema: a case report.
    Más AM; Villegas VM; García JM; Acevedo S; Serrano L
    P R Health Sci J; 2012 Sep; 31(3):148-50. PubMed ID: 23038888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab for peripapillary choroidal neovascular membranes.
    Davis AS; Folk JC; Russell SR; Sohn EH; Boldt HC; Stone EM; Mahajan VB
    Arch Ophthalmol; 2012 Aug; 130(8):1073-5. PubMed ID: 22893085
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripapillary choroidal neovascular membrane in a teenage boy: presenting feature of idiopathic intracranial hypertension and resolution with intravitreal bevacizumab.
    Belliveau MJ; Xing L; Almeida DR; Gale JS; ten Hove MW
    J Neuroophthalmol; 2013 Mar; 33(1):48-50. PubMed ID: 23403388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.
    Melamud A; Stinnett S; Fekrat S
    Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab (avastin) for choroidal neovascularization associated with deferoxamine retinopathy.
    Duval R; Olivier S
    Retin Cases Brief Rep; 2011; 5(3):233-6. PubMed ID: 25390172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab in the treatment of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension.
    Lee IJ; Maccheron LJ; Kwan AS
    J Neuroophthalmol; 2013 Jun; 33(2):155-7. PubMed ID: 23235432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab for treatment of peripapillary subretinal neovascularization.
    Caccavale A; Imparato M; Negri A
    Retin Cases Brief Rep; 2008; 2(2):145-7. PubMed ID: 25389827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Rich RM; Rosenfeld PJ; Puliafito CA; Dubovy SR; Davis JL; Flynn HW; Gonzalez S; Feuer WJ; Lin RC; Lalwani GA; Nguyen JK; Kumar G
    Retina; 2006; 26(5):495-511. PubMed ID: 16770255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab in the management of posttraumatic choroidal neovascular membrane.
    Rishi P; Shroff D; Rishi E
    Retin Cases Brief Rep; 2008; 2(3):236-8. PubMed ID: 25390097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravitreal injections of ranibizumab in treatment of large peripapillary choroidal neovascularization].
    Nochez Y; Le Lez ML; Pisella PJ
    J Fr Ophtalmol; 2009 Jan; 32(1):25-31. PubMed ID: 19515310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab for neovascular ocular diseases.
    Lynch SS; Cheng CM
    Ann Pharmacother; 2007 Apr; 41(4):614-25. PubMed ID: 17355998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of choroidal neovascularization complicating a choroidal osteoma with intravitreal bevacizumab.
    Rao S; Gentile RC
    Retin Cases Brief Rep; 2010; 4(4):303-5. PubMed ID: 25390904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization overlying choroidal osteoma.
    Shields CL; Salazar PF; Demirci H; Benson WE; Shields JA
    Retin Cases Brief Rep; 2008; 2(1):18-20. PubMed ID: 25389607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.
    Weigert G; Michels S; Sacu S; Varga A; Prager F; Geitzenauer W; Schmidt-Erfurth U
    Br J Ophthalmol; 2008 Mar; 92(3):356-60. PubMed ID: 18303156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
    Alkawas AA; Shahien EA; Hussein AM
    J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab and neovascular age related macular degeneration: pathogenesis and treatment.
    El-Mollayess GM; Noureddine BN; Bashshur ZF
    Semin Ophthalmol; 2011 May; 26(3):69-76. PubMed ID: 21609219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
    Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
    Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6- and 9-month results.
    Cleary CA; Jungkim S; Ravikumar K; Kelliher C; Acheson RW; Hickey-Dwyer M
    Eye (Lond); 2008 Jan; 22(1):82-6. PubMed ID: 17891059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.